Novel Allocation Strategies Can Boost Kidney Exchange Programs: A Monte Carlo Simulation
Kidney exchange programs (KEPs) enhance access to living donor kidney transplantation. Nonetheless, transplant rates in KEP remain low for highly immunized and blood type O patients. In the Netherlands, a novel allocation algorithm is being implemented, allowing ABO-incompatible matching for long waiting patients, next to prioritization and 'low-level' HLA-incompatible matching for selected highly immunized patients. We simulated this novel algorithm along with additional scenarios, by using a retrospective, 6-year cohort of Dutch KEP. For each scenario, 30 simulations were repeated with Monte Carlo technique. The novel algorithm increased median KEP transplant rate for incompatible pairs (53% versus 44%, p < 0.001) and for difficult-to-match subgroups. HLA-incompatible matching increased transplant rate for selected highly immunized patients significantly, while participation with multiple donors per recipient did not. In additional simulations, including all non-KEP unspecified donors (n = 150) for local KEP participation increased transplant rate for incompatible pairs up to 64% (p < 0.001). Simulating additional KEP participation by compatible pairs (n = 149), on the condition a KEP match should have fewer HLA mismatches, resulted in 58% being matched in KEP. In conclusion, differential matching algorithms can boost KEP transplant rates, allowing incompatible matching for difficult-to-match subgroups, facilitating participation of unspecified donors, and optimizing the HLA matching of compatible pairs.
Authors
- Annelies E. de Weerd (ORCID: https://orcid.org/0000-0001-5134-2025)
- Joke I. Roodnat (ORCID: https://orcid.org/0000-0003-2548-5481)
- Kristiaan Glorie
- Sebastiaan Heidt (ORCID: https://orcid.org/0000-0002-6700-188X)
- Dave L. Roelen (ORCID: https://orcid.org/0000-0002-1846-1193)
- Laura Bungener (ORCID: https://orcid.org/0000-0001-5016-5792)
- Eric Spierings (ORCID: https://orcid.org/0000-0001-9441-1019)
- Twan Dollevoet (ORCID: https://orcid.org/0000-0003-3193-823X)
- Aline C. Hemke
- Jeroen D. Langereis (ORCID: https://orcid.org/0000-0001-5317-3202)
- Maarten H. L. Christiaans (ORCID: https://orcid.org/0000-0003-3558-2277)
- Claudia Ranzijn
- Judith A. Kal-van Gestel
- Mattheüs F. Klaassen
- Margriet F. C. de Jong
- Marcia M. L. Kho
- Jacqueline van de Wetering
- Christina E. M. Voorter
- Karlijn A. M. I. van der Pant
- Arjan D. van Zuilen
- Marry de Klerk
- Hanneke Bouwsma
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Erasmus MC (NL)
- University Medical Center (US)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Musculoskeletal Transplant Foundation (US)
- Immungenetics (Germany) (DE)
- Erasmus MC Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Transplant International
- Published
- 2026-03-04
- DOI
- https://doi.org/10.3389/ti.2026.15423
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Nierstichting